English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Objective  To study trends in use of antidepressants (ADs) by adolescents, and psychiatric morbidity and use of other psychotropic drugs as a measure of psychiatric comorbidity.    Methods  One‐year prevalence of  AD  drug use was analyzed for 13‐ to 17‐year‐old Norwegians during 2004–2013. Use of other psychotropic drugs and specialist healthcare services was analyzed for incident  AD  users in 2012, using linked data from the Norwegian Prescription Database and the Norwegian Patient Register.    Results  The 1‐year prevalence of  AD  drug use increased from 6.4/1000 to 9.1/1000 during 2004–2013, with the steepest increase from 2010, particularly among girls. The highest prevalence was found in 17‐year‐old girls (17.8/1000 in 2010, 27.5/1000 in 2013). Of incident  AD  drug users in 2012, 84.4% had been in contact with specialist health care. As the first drug, 78.4% were prescribed a selective serotonin reuptake inhibitor. The most common types of other psychotropic drugs were melatonin (24.6%), antipsychotic drugs (13.2%), stimulants (8.8%), and anxiolytics (6.0%).    Conclusions  Use of  AD s among adolescents has increased over the last 3–4 years, particularly among 16‐ to 17‐year‐old girls. A total of 85% of incident users had been in contact with specialist health care, which may indicate that drug‐therapy is used by adolescents with more severe symptoms.

Antidepressant drug use among adolescents during 2004–2013: a population‐based register linkage study